Shanghai Haohai Biological Technology Co Ltd (fra:5HB) Share Price

Company Profile

Business description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
Contact
No. 1386 Hongqiao Road
23rd Floor, WenGuang Plaza
Changning District
Shanghai
CHN
T: +86 2152293555
https://www.3healthcare.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2,156

Recommended

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.

Brian Colello, CPA | 19 September 2025

Our Fair Value estimate once again reflects the stand-alone business and its growth potential.

Mark Taylor | 19 September 2025

Coverage of ASX listed REIT as investor interest in property continues to grow.

Yingqi Tan, CFA | 19 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,103.90	22.20	0.24%
CAC 40	7,854.61	67.63	0.87%
DAX 40	23,674.53	315.35	1.35%
Dow JONES (US)	46,142.42	124.10	0.27%
FTSE 100	9,228.11	19.74	0.21%
HKSE	26,521.40	23.45	-0.09%
NASDAQ	22,470.72	209.40	0.94%
Nikkei 225	45,623.05	319.62	0.71%
NZX 50 Index	13,263.08	143.05	1.09%
S&P 500	6,631.96	31.61	0.48%
S&P/ASX 200	8,815.60	23.40	0.27%
SSE Composite Index	3,827.02	4.64	-0.12%